MedTrace Logo

Radicle GI Health RAATM: A Study Assessing the Impact of Health and Wellness Products on Gastrointestinal-Related Quality of Life and Related Health Outcomes

NCT07653776 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 550

Last updated 2026-08-20

No results posted yet for this study

Summary

Radicle GI Health RAA: A randomized, double-blind, placebo- controlled direct-to-consumer study assessing the impact of health and wellness products on gastrointestinal-related quality of life and related health outcomes.

Conditions

  • Digestion-associated Quality of Life

Interventions

DIETARY_SUPPLEMENT

Placebo GI Health Control

Participants will use their Placebo GI Health Control as directed for a period of 8 weeks

DIETARY_SUPPLEMENT

Active GI Health Product 1

Participants will use their Active GI Health Product 1 as directed for a period of 8 weeks"

Sponsors & Collaborators

  • Radicle Science

    lead INDUSTRY

Principal Investigators

  • Susan Hewlings · Radicle Science

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
105 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-15
Primary Completion
2027-06-12
Completion
2027-06-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07653776 on ClinicalTrials.gov